510(k) Report

510(k) · Cleared

Recalled · Class II · 2019

Tina-Quant Myoglobin Gen.2 Test System

K061683510(k) TraditionalCleared Jul 21, 200636-day reviewClass II21 CFR 866.5680Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · DDR Myoglobin, Antigen, Antiserum, Control

Cleared on Jul 21, 2006 as substantially equivalent to K972513 (Boehringer Mannheim Corp., 1997) after a 36-day review. Its family tree reaches back 2 generations to 1990. 1 later device descends from it. It has been recalled once.

Decided
Jul 21, 2006
Review
36 days
Class
Class II
Product code
DDR
Recalls
1
Predicates
1

Its longest line of descent runs back 2 generations to K902154 (1990). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2013: 1 descendant clearedK902154 · NA Latex Myoglobin Test · Behring Diagnostics, Inc. · 1990K972513 · Tinaquant Myoglobin Assay · Boehringer Mannheim Corp. · 19971990200020102020
Descendants, by generation 1 generation forward: 1 descendant K972513 · Tinaquant Myoglobin Assay · Boehringer Mannheim Corp. · 1997K902154 · NA Latex Myoglobin Test · Behring Diagnostics, Inc. · 19900
  1. Root · 2 generations backK902154 NA Latex Myoglobin TestBehring Diagnostics, Inc. · 1990
  2. 1 generation backK972513 Tinaquant Myoglobin AssayBoehringer Mannheim Corp. · 1997
  3. This deviceK061683 Tina-Quant Myoglobin Gen.2 Test SystemRoche Diagnostics Corp. · 2006
  4. Descendant · cites it directly · 0 of its ownK123785 Diazyme Myoglobin; Assay, Calibrator Set, Control SetDiazyme Laboratories · 2013

Most influential descendants

Showing 1 of 1 · See all
  • K123785Diazyme Myoglobin; Assay, Calibrator Set, Control SetDiazyme Laboratories · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K902154NA Latex Myoglobin TestBehring Diagnostics, Inc.1990—
−1K972513Tinaquant Myoglobin AssayBoehringer Mannheim Corp.1997—
0 (this device)K061683Tina-Quant Myoglobin Gen.2 Test SystemRoche Diagnostics Corp.2006—
+1K123785Diazyme Myoglobin; Assay, Calibrator Set, Control SetDiazyme Laboratories2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
FIG. 1 — Lineage of K061683, 1990–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DDR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DDR device

  1. #1 K231832 Access Myoglobinscore 6.3 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972513Tinaquant Myoglobin Assay
Summary page 1
…nt® Myoglobin Gen.2 test system is substantially equivalent to devices the currently marketed Tina-Quant ®9 Myoglobin Test System cleared under K9725 13. Device The Tina-Quant®V Gen.2 Test System is an immunoturbidimetric assay for the Description quantitative in v…
Boehringer Mannheim Corp.1997—

Also cleared against K972513: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K123785Diazyme Myoglobin; Assay, Calibrator Set, Control SetDiazyme Laboratories20130

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 2, 2019Class IIZ-2445-2019Under Investigation by firmThe firm conducted internal investigations that confirmed customer complaints of quality control (QC) imprecision and calibration failures for the Tina-quant Myoglobin Gen.2 assay (catalog number 04580010190), lot number 349860 on the…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 3 companies; a new generation was cleared every 9.0 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K123785 (Diazyme Laboratories, 2013) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K972513.

How does its category compare?

All DDR devices

DDR Myoglobin, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DDR

1in 2023

2009: 22012: 12013: 12023: 1
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DDR

Too few DDR 510(k)s in any year since 2007 to give a median.

Recalls per year · DDR

2in 2015

2007: 22009: 12015: 2
2007high 2 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DDR

5in 2025

2009: 32011: 52012: 22013: 32014: 12016: 32017: 52018: 32019: 62020: 22021: 12022: 12023: 72024: 312025: 5
2007high 31 (2024) · low 0 (2007)2025

MAUDE reports naming product code DDR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—20
20080—00
20092—13
20100—00
20110—05
20121—02
20131—03
20140—01
20150—20
20160—03
20170—05
20180—03
20190—06
20200—02
20210—01
20220—01
20231—07
20240—031
20250—05
20260—0—

What is it indicated for?

The Tina-Quant ® Myoglobin Gen.2 Test System is an immunoturbidimetric assay for the quantitative in vitro determination of myoglobin in human serum and plasma on Roche automated clinical chemistry analyzers. Measurement of myoglobin aids in the rapid diagnosis of heart and renal disease.

C.f.a.s. (Calibrator for automated systems) Myoglobin is for use in the calibration of quantitative Roche methods on Roche clinical chemistry analyzers as specified in the enclosed value sheet.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K061683: Tina-Quant Myoglobin Gen.2 Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K061683

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026